Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_assertion type Assertion NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_head.
- NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_assertion description "[Genetic alterations in gliomas that are being used in classification include TP53 and retinoblastoma pathway disruption, PTEN mutations, epidermal growth factor receptor amplification and 1p/19q losses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_provenance.
- NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_assertion evidence source_evidence_literature NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_provenance.
- NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_assertion SIO_000772 15853584 NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_provenance.
- NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_assertion wasDerivedFrom befree-20140225 NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_provenance.
- NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_assertion wasGeneratedBy ECO_0000203 NP279786.RAbBqQXvYwMBV-XELgWEZrye1JeyqjvvYQhJEgy9UrW-w130_provenance.